Please use this identifier to cite or link to this item:
Title: The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical Trials
Authors: Giuliani, Jacopo 
Bonetti, Andrea
Keywords: Advanced colorectal cancer;Costs of drugs;First-line chemotherapy;Randomized phase II and phase III trials;Targeted biological therapies
Mesh headings: Colorectal Neoplasms;Drug Therapy;Hepatectomy
Secondary Mesh headings: Humans
Issue Date: Dec-2016
Journal: Journal of gastrointestinal cancer 
The aim of this study was to evaluate the pharmacological costs of conversion chemotherapy with targeted biological agents in an unselected population of advanced colorectal cancer (CRC) patients in order to achieve an R0 liver resection.
ISSN: 19416628
DOI: 10.1007/s12029-016-9862-0
Appears in Collections:Articles

Show full item record

PubMed Central
Citations 50

Last Week
Last month
checked on Aug 8, 2021

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.